Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02014636 |
| Title | Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC) |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Novartis Investigative Site | Boston | Massachusetts | 02115 | United States | Details | |
| Novartis Investigative Site | Boston | Massachusetts | 02215 | United States | Details | |
| Novartis Investigative Site | New York | New York | 10065 | United States | Details | |
| Novartis Investigative Site | Nashville | Tennessee | 37203 | United States | Details | |
| Novartis Investigative Site | Manchester | Lancashire | M20 4BX | United Kingdom | Details | |
| Novartis Investigative Site | London | W1G 6AD | United Kingdom | Details |